{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/67915682"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/380774034" ] } },

    { "id" : "http://webisa.webdatacommons.org/380774034"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Participants acknowledged that the appetite for investing in biotechnology is a fraction of what it was fifteen years ago and cited the need to invent new models for investment, including venture philanthropy and balanced partnerships with the pharmaceutical industry that are transparent and have similar interests. ???Academic institutions are starting to build the infrastructure where noble ideas" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "prweb.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/415607764"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/380774034"] } } }
